Constitutive activation of NF-κB is observed in a large subset of ovarian tumors, is associated with tumor growth, progression and resistance to chemotherapy, and is an important molecular link between inflammation and cancer [4–9]. This evidence concerns the gene NFKB1 and ovarian neoplasm.